4//SEC Filing
Mathew Aby J. 4
Accession 0001628280-25-012679
CIK 0000834365other
Filed
Mar 12, 8:00 PM ET
Accepted
Mar 13, 5:26 PM ET
Size
5.1 KB
Accession
0001628280-25-012679
Insider Transaction Report
Form 4
Mathew Aby J.
EVP & Chief Scientific Officer
Transactions
- Sale
Common Stock
2025-03-11$25.00/sh−1,597$39,925→ 260,601 total
Footnotes (1)
- [F1]The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 03-08-2024 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.
Documents
Issuer
BIOLIFE SOLUTIONS INC
CIK 0000834365
Entity typeother
Related Parties
1- filerCIK 0001556355
Filing Metadata
- Form type
- 4
- Filed
- Mar 12, 8:00 PM ET
- Accepted
- Mar 13, 5:26 PM ET
- Size
- 5.1 KB